Pricing Log in Create free account

Anebulo Pharmaceuticals, Inc. (ANEB) vs Neuphoria Therapeutics Inc. (NEUP)

Anebulo Pharmaceuticals, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Neuphoria Therapeutics Inc. are of similar size ($17.9M and $17.6M). Across the 9 metrics below, Neuphoria Therapeutics Inc. leads on 5 and Anebulo Pharmaceuticals, Inc. on 4.

Valuation

Metric ANEB NEUP Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.91 9.71
P/B n/m 0.58 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.03 0.27 0.64
EV/Sales n/m (0.30) 9.21
Earnings yield 0.00% (154.60%) (33.15%)
Free cash flow yield 0.00% (85.14%) (25.50%)

Profitability

Metric ANEB NEUP Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.69%) (61.70%) (56.36%)
Return on assets (63.17%) (46.95%) (48.04%)
Return on invested capital 0.00% (232.67%) 0.00%

Growth

Metric ANEB NEUP Biotechnology median
Revenue growth (TTM) — 3,535.05% 6.02%
EPS growth (last fiscal year) 21.88% (1,230.43%) 30.26%
Revenue growth, 5-year CAGR — 19.07% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANEB NEUP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.24 27.85 4.72
Net debt to EBITDA 1.32 1.26 0.96

Dividend

Metric ANEB NEUP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANEB NEUP Biotechnology median
Market cap 17.60m 17.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack